EP Patent

EP4316592A2 — Carbamoyl phenylalaninol compounds and uses thereof

Assigned to Axsome Malta Ltd · Expires 2024-02-07 · 2y expired

What this patent protects

The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders.

USPTO Abstract

The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders.

Drugs covered by this patent

solriamfetol-hydrochloride (SOLRIAMFETOL HYDROCHLORIDE)

Patent Metadata

Patent number: EP4316592A2
Jurisdiction: EP
Classification: —
Expires: 2024-02-07
Drug substance claim: No
Drug product claim: No
Assignee: Axsome Malta Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.